Tirzepatide is FDA-approved (for diabetes and weight loss, depending on the brand) and works as a dual-agonist, targeting GLP-1 and GIP receptors to reduce appetite, improve insulin response, and support weight loss
Los agonistas (las sustancias que se unen al receptor celular para producir una respuesta) del GLP 1 son un grupo de medicamentos que ayudan, principalmente, a controlar los niveles de azcar en la sangre (glucosa) en las personas que padecen diabetes tipo 2
A study of 28 people aged 18 to 64 by the British Journal of Dermatology details some of the side effects they commonly experienced
How Long Does It Take Retatrutide to Reduce Appetite
Comparative review of SSRIs
Peppermint tea or capsules may ease bloating for some individuals, though should be avoided if you experience reflux or heartburn, which can also occur with GLP-1 medications